244 related articles for article (PubMed ID: 23090495)
1. Aberrant plasticity and "learned" motor inhibition in Parkinson's disease.
Zhuang XX
Sheng Li Xue Bao; 2012 Oct; 64(5):543-9. PubMed ID: 23090495
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic treatment weakens medium spiny neuron collateral inhibition in the parkinsonian striatum.
Wei W; Ding S; Zhou FM
J Neurophysiol; 2017 Mar; 117(3):987-999. PubMed ID: 27927785
[TBL] [Abstract][Full Text] [Related]
3. Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors.
Fasano C; Bourque MJ; Lapointe G; Leo D; Thibault D; Haber M; Kortleven C; Desgroseillers L; Murai KK; Trudeau LÉ
Neuropharmacology; 2013 Apr; 67():432-43. PubMed ID: 23231809
[TBL] [Abstract][Full Text] [Related]
4. Long-term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through κ-opioid receptors.
Hawes SL; Salinas AG; Lovinger DM; Blackwell KT
J Physiol; 2017 Aug; 595(16):5637-5652. PubMed ID: 28449351
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity.
Centonze D; Grande C; Saulle E; Martin AB; Gubellini P; Pavón N; Pisani A; Bernardi G; Moratalla R; Calabresi P
J Neurosci; 2003 Sep; 23(24):8506-12. PubMed ID: 13679419
[TBL] [Abstract][Full Text] [Related]
6. Differential striatal spine pathology in Parkinson's disease and cocaine addiction: a key role of dopamine?
Villalba RM; Smith Y
Neuroscience; 2013 Oct; 251():2-20. PubMed ID: 23867772
[TBL] [Abstract][Full Text] [Related]
7. The effect of dopamine on response inhibition in Parkinson's disease relates to age-dependent patterns of nigrostriatal degeneration.
Kübler D; Schroll H; Hamker FH; Joutsa J; Buchert R; Kühn AA
Parkinsonism Relat Disord; 2019 Jun; 63():185-190. PubMed ID: 30765262
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic control of synaptic plasticity in the dorsal striatum.
Centonze D; Picconi B; Gubellini P; Bernardi G; Calabresi P
Eur J Neurosci; 2001 Mar; 13(6):1071-7. PubMed ID: 11285003
[TBL] [Abstract][Full Text] [Related]
9. Synaptic dysfunction in Parkinson's disease.
Picconi B; Piccoli G; Calabresi P
Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
[TBL] [Abstract][Full Text] [Related]
11. RGS Proteins as Critical Regulators of Motor Function and Their Implications in Parkinson's Disease.
Ahlers-Dannen KE; Spicer MM; Fisher RA
Mol Pharmacol; 2020 Dec; 98(6):730-738. PubMed ID: 32015009
[TBL] [Abstract][Full Text] [Related]
12. D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons.
Surmeier DJ; Ding J; Day M; Wang Z; Shen W
Trends Neurosci; 2007 May; 30(5):228-35. PubMed ID: 17408758
[TBL] [Abstract][Full Text] [Related]
13. Aberrant learning in Parkinson's disease: A neurocomputational study on bradykinesia.
Ursino M; Baston C
Eur J Neurosci; 2018 Jun; 47(12):1563-1582. PubMed ID: 29786160
[TBL] [Abstract][Full Text] [Related]
14. Treadmill exercise reverses dendritic spine loss in direct and indirect striatal medium spiny neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Toy WA; Petzinger GM; Leyshon BJ; Akopian GK; Walsh JP; Hoffman MV; Vučković MG; Jakowec MW
Neurobiol Dis; 2014 Mar; 63():201-9. PubMed ID: 24316165
[TBL] [Abstract][Full Text] [Related]
15. Differential dopaminergic regulation of inwardly rectifying potassium channel mediated subthreshold dynamics in striatal medium spiny neurons.
Zhao B; Zhu J; Dai D; Xing J; He J; Fu Z; Zhang L; Li Z; Wang W
Neuropharmacology; 2016 Aug; 107():396-410. PubMed ID: 27018450
[TBL] [Abstract][Full Text] [Related]
16. Role of dopamine receptors in the short- and long-term regulation of corticostriatal transmission.
Calabresi P; Pisani A; Centonze D; Bernardi G
Nihon Shinkei Seishin Yakurigaku Zasshi; 1997 Apr; 17(2):101-4. PubMed ID: 9201731
[TBL] [Abstract][Full Text] [Related]
17. Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum.
Calabresi P; Maj R; Mercuri NB; Bernardi G
Neurosci Lett; 1992 Aug; 142(1):95-9. PubMed ID: 1357611
[TBL] [Abstract][Full Text] [Related]
18. Dopaminergic Modulation of Striatal Inhibitory Transmission and Long-Term Plasticity.
Nieto Mendoza E; Hernández Echeagaray E
Neural Plast; 2015; 2015():789502. PubMed ID: 26294980
[TBL] [Abstract][Full Text] [Related]
19. Striatal Neurons Expressing D
Gagnon D; Petryszyn S; Sanchez MG; Bories C; Beaulieu JM; De Koninck Y; Parent A; Parent M
Sci Rep; 2017 Jan; 7():41432. PubMed ID: 28128287
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
